Navigation Links
Drug control efforts in Mexico reduce methamphetamine treatment admissions in Mexico and US
Date:8/5/2010

A study published today in the scientific journal Addiction shows that the Mexican government's recent efforts to control the manufacture of methamphetamine have caused a drop in methamphetamine treatment admissions in Mexico and in neighbouring Texas.

In 2005 Mexico began controlling its imports of pseudoephedrine (a precursor chemical used in the manufacture of methamphetamine), and in 2008 it became the first country in North America to ban all imports of pseudoephedrine as well as ephedrine, another important precursor chemical. Researchers estimate that the 2005 import controls caused a 12% drop in voluntary methamphetamine treatment admissions in Mexico, with similar reductions in Texas.

An even larger drop in voluntary admissions occurred following the 2007 closure of a commercial chemical company suspected of illicitly importing more than 60 tons of pseudoephedrine into Mexico. The head of the company fled Mexico but was eventually arrested in the United States. Methamphetamine treatment admissions in Mexico decreased by 56% following the closure of the company, with Texas showing similar results.

All decreases in admissions appeared to be specific to methamphetamine, as researchers found no concurrent changes in cocaine, heroin, and alcohol treatment admissions during the same period. The study wound up shortly after the 2008 bans on precursor chemicals came into effect, so researchers weren't able to examine fully the impact of those bans; however, the researchers noted that treatment admissions in Mexico showed signs of declining in the first few months following the bans.

Says lead researcher James Cunningham, a Fulbright Scholar at The University of Arizona: "These findings constitute the first evidence outside the United States that a country's precursor chemical controls can have positive public health results both domestically and internationally."


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Caltech biologists discover microRNAs that control function of blood stem cells
2. UCSD scientists find gas pedal -- and brake -- for uncontrolled cell growth
3. FDA accepts historical controls for epilepsy monotherapy studies
4. Duke and African partners to study sustainable malaria control
5. Can Self-Hypnosis Help Tourette Patients Control Tics?
6. Radiation device allows for targeted breast radiation to control cancer
7. Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use
8. Tight Blood Pressure Control Doesnt Help All Diabetics: Study
9. With magnetic nanoparticles, scientists remotely control neurons and animal behavior
10. Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk
11. Internists outline comprehensive federal strategy to control tobacco use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... ... development of it’s new program “Designing Secure Healthcare Systems” This three-day, highly ... technology leaders from healthcare organizations with access to the tactics, techniques and practices ...
(Date:8/3/2015)... ... ... The U.S. Food and Drug Administration (FDA) recently approved a new non-invasive ... occurs naturally in the body and helps absorb and breakdown fat cells. Previously, plastic ... These are invasive procedures and very expensive for most people. Now with Kybella, there ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from ... Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses ... the report, the new study showed that harvesting stem cell-rich bone marrow from the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Illinois Health & ... July 31. , The acquisition includes all of IBAM NA’s cyclotron sites and ... have both, a robust regionally located business, as well as a large manufacturing hub ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... firm, announced today that Joe Williams has joined its growing California employee benefits ... HUB's differentiated service model to his clients. Mr. Williams will be joining the ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2
... DENVER, June 24 The National Sports Center for the Disabled and American ... Classic from Friday, July 17th to Sunday, July 19th at the Winter Park ... with a wide variety of well-marked trails for all levels of riders and ... , World Class Mountain Biking! , ...
... researchers say , , WEDNESDAY, June 24 (HealthDay ... well in an early clinical trial against breast, ovarian ... to developing these malignancies. , Women who carry BRCA1 ... and ovarian cancer, and among men these mutations are ...
... 24 Validation and Compliance Institute (VCI), which provides ... industries, will offer a series of Dietary Supplement Good ... division of NSF International. , , ... GMP regulations for dietary supplements, which the US Food ...
... 24 Speaker Nancy Pelosi held a brief a press availability ... , Jim Douglas of Vermont , and Chris Gregoire ... to discuss health care reform. Below are their remarks: ... indeed to welcome three very distinguished governors to The Speaker,s Office - ...
... , ROCHESTER, Minn., June 24 The Mayo Clinic ... collaborative symposium on innovations in health care experience and ... open to the public. It will feature nationally recognized ... in health care delivery models, including Web-based tools. The ...
... biomarkers in patients with only mild memory problems , ... disease can be detected in the cerebrospinal fluid in ... study suggests. , University of Gothenburg researchers analyzed cerebrospinal ... typical pattern of biomarkers known as the "CSF AD ...
Cached Medicine News:Health News:18th Annual Fat Tire Classic Benefiting the National Sports Center for the Disabled & the American Red Cross Mile High July 17th - 19th, 2009 2Health News:New Cancer Drug Fights Tumors in Those With BRCA Mutations 2Health News:New Cancer Drug Fights Tumors in Those With BRCA Mutations 3Health News:Validation & Compliance Institute, LLC, to Provide Dietary Supplement GMP Training for NSF International 2Health News:Pelosi, Governors' Remarks Before Meeting on Health Care 2Health News:Pelosi, Governors' Remarks Before Meeting on Health Care 3Health News:Pelosi, Governors' Remarks Before Meeting on Health Care 4Health News:Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery 2Health News:Mayo Clinic Center for Innovation to Sponsor a Collaborative Symposium on Innovations in Health Care Experience and Delivery 3Health News:Clues to Alzheimer's Spotted Earlier in Disease 2
(Date:8/3/2015)... Fla. , Aug. 3, 2015  Charleston ... initiation of its second clinical development program with ... candidate, CL-H1T.  CL-H1T contains fast-dissolving ... being developed as a treatment for migraine headache ... "Many patients with migraine headaches also ...
(Date:8/3/2015)... Aug. 3, 2015  Encision Inc. (PK:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... ended June 30, 2015. The Company posted ... net loss of $213 thousand, or $(0.02) per share. ... for a net loss of $202 thousand, or $(0.02) ...
(Date:8/2/2015)... August 3, 2015 Mandatory ... Pharmaceuticals PLC ("Dechra" or the "Company") is pleased to ... ("SPA") with Mr. Marijan Han žeković to acquire ... Genera d.d. ("Genera"), a Croatian listed pharmaceutical business.   ... which is equivalent to €51.4 million for the entire ...
Breaking Medicine Technology:Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5
... 5, 2012  Quest Diagnostics Incorporated (NYSE: DGX ), ... announced that it will report fourth quarter and full year ... January 24, 2012 before the market opens. It will hold its ... a.m. Eastern Time on that day. The public ...
...  DURECT Corporation (Nasdaq: DRRX ) announced today ... study for POSIDUR® known as BESST (Bupivacaine Effectiveness and ... relief depot that utilizes DURECT,s patented SABER™ technology to ... three days of pain relief after surgery.  BESST was ...
Cached Medicine Technology:Quest Diagnostics to Release Fourth Quarter and Full Year 2011 Financial Results 2DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) 2DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) 3DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) 4DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) 5
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: